← Eichor
Study identifier: NCT05558059 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Imaging Retinal Vasculature in Infant Eyes

Condition: Retinopathy of Prematurity  ·  Sponsor: Duke University

PhaseN/A
Planned participants16
Who can joinAll sexes, N/A to 2 Months
Healthy volunteersNo

About this study

Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a critical location in the retina determining visual acuity and visual function, and the blood vessels around it, are abnormally developed in infants with retinopathy of prematurity. However, how these blood vessels form during development of the human fovea remains unclear. This research will advance our understanding of the fundamental knowledge of how the blood vessels around the fovea form in infants, and how they change in diseased states such as preterm birth or retinopathy of prematurity.

This description comes directly from the study's public registry record.

Talk to the study team

Xi Chen, MD  ·  (919) 684-8434  ·  xi2.chen@duke.edu

Michelle N McCall  ·  (919) 684-0544  ·  michelle.mccall@duke.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Duke UniversityDurham, North Carolina, United StatesRecruiting
University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05558059